Primary Record
Paroxetine maleate
- In stock
- 9,882 g
- Purity
- 98.9 %
- CAS
- 64006-44-6
Compound Identifiers & Properties
- CAS
- 64006-44-6
- PubChem CID
- 6435921
- SMILES
- C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.C(=C\C(=O)O)\C(=O)O
- Canonical SMILES
- Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1.O=C(O)/C=C\C(=O)O
Names & Synonyms
- Paroxetine maleate
- paroxetine
- FG 7051 maleate
- 64006-44-6
- fg7051maleate
- Paroxetine maleate
- Paroxetine maleate salt
- Paroxetine (maleate)
- PS21 - Paroxetine
- AC1O5KQP
- RefChem:858694
- FG-7051 MALEATE
- GF 74
- DTXSID9042590
- UNII-F726G2563Q
- CHEBI:64194
- MLS000758308
- MLS001076681
- MLS001401441
- SCHEMBL140608
- C23H24FNO7
- orb1705581
- PAROXETINE MALEATE [MI]
- CHEMBL1449490
- F726G2563Q
- C19H20FNO3.xC4H4O4
- DTXCID60819892
- AEIUZSKXSWGSRU-QXGDPHCHSA-N
- C19H20FNO3.C4H4O4
- C19H20NO3F.C4H4O4
- REGID_for_CID_6435921
- GLXC-04179
- HMS2051I21
- HMS2230L21
- HMS2231N17
- HMS3268L15
- HMS3413G13
- HMS3677G13
- BRL-29060
- MFCD01742665
- AKOS024456951
- CCG-100827
- CID6435921
- NC00077
- AN-38851
- AS-87676
- CPD000466269
- FP102559
- O648
- SAM001246991
- SMR000466269
- SMR000499580
- HY-110029
- LS-114250
- C19-H20-F-N-O3.x-C4-H4-O4
- CS-0032850
- FT-0630742
- G78453
- Paroxetine maleate salt, >=98% (HPLC), solid
- (-)-alpha-4-(4-Fluorophenyl)-3-(1,3-benzdioxolyl-(3))-oxymethyl piperidine maleate
- 006P446
- SR-01000597775
- trans-(-)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine maleate
- SR-01000597775-1
- Q27133113
- (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine maleate
- (3S-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine maleate salt
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;(Z)-but-2-enedioic acid
- Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-(-)-, (Z)-2-butenedioate
- (3S)-trans-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine maleate
- (3S,4R)-3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)-PIPERIDINE MALEATE
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine; maleic acid
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;maleic acid
- (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine maleate
- (2Z)-But-2-enedioic acid--(3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine (1/1)
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine; (Z)-but-2-enedioic acid
- (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine (2Z)-but-2-enedioate
- (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidinium (2Z)-3-carboxyacrylate
- 636-343-3
- Paroxetine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
- Paroxetine Maleate; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-, (2Z)-2-butenedioate (1:1); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S-trans)-, (Z)-2-butenedioate; FG 7051 maleate; Paroxetine maleate; Paroxetine maleate (1:1)
- Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S,4R)-, (2Z)-2-butenedioate (1:1)